Stocks and InvestingStocks and Investing
Fri, October 22, 2021
Thu, October 21, 2021
Wed, October 20, 2021
Tue, October 19, 2021

Matthew Harrison Downgraded (AKRO) to Hold and Held Target at $27 on, Oct 19th, 2021


Published on 2024-10-27 18:13:29 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Downgraded "Akero Therapeutics, Inc." (AKRO) to Hold and Held Target at $27 on, Oct 19th, 2021.

Matthew has made no other calls on AKRO in the last 4 months.



There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Aspen Mori of "B of A Securities" Initiated at Strong Buy and Held Target at $40 on, Friday, September 10th, 2021
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $64 on, Monday, August 16th, 2021